mycobacterial cell wall-dna complex
Biologicalexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
3
Phase 4
0
Earliest trial started Nov 1, 2006 (NCT00406068)
Timeline
Indications
Mechanism of action
- Mycobacterium tuberculosisImmunity, active
Mycobacterium tuberculosis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- en3348
- mycobacterial cell wall-dna complex
- mycobacterial cell wall-dna complex
- mycobacterial cell-wall dna complex
- mycobacterial cell-wall dna complex
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01200992 | Phase 3 | Nov 1, 2010 | Telesta Therapeutics |
| NCT01284205 | Phase 3 | Jan 1, 2010 | Telesta Therapeutics |
| NCT00406068 | Phase 2/Phase 3 (Phase 3) | Nov 1, 2006 | Queen's University, Belfast, Telesta Therapeutics |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Telesta Therapeutics | For profit | 3 | 3 | 1 | 2006 |
| Queen's University, Belfast | Academic/Hospital | 1 | 0 | 1 | 2006 |
2 organizations
Page 1 / 1